Mesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) declared a quarterly dividend on Monday, April 7th, RTT News reports. Stockholders of record on Friday, May 30th will be given a dividend of 0.16 per share by the medical instruments supplier on Monday, June 16th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date is Friday, May 30th.
Mesa Laboratories has a dividend payout ratio of 7.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Mesa Laboratories to earn $8.72 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.3%.
Mesa Laboratories Stock Up 4.3 %
MLAB traded up $4.71 during trading on Friday, reaching $114.57. The stock had a trading volume of 35,186 shares, compared to its average volume of 38,871. The company has a current ratio of 0.71, a quick ratio of 0.53 and a debt-to-equity ratio of 0.61. The company has a market capitalization of $622.57 million, a price-to-earnings ratio of -2.48 and a beta of 0.92. The stock's 50 day moving average is $130.23 and its two-hundred day moving average is $128.20. Mesa Laboratories has a one year low of $83.68 and a one year high of $155.12.
Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. As a group, analysts expect that Mesa Laboratories will post 8 earnings per share for the current year.
Insider Transactions at Mesa Laboratories
In related news, CEO Gary M. Owens sold 21,000 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total value of $2,602,110.00. Following the transaction, the chief executive officer now owns 43,337 shares in the company, valued at $5,369,887.67. The trade was a 32.64 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 4.40% of the company's stock.
About Mesa Laboratories
(
Get Free Report)
Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
Featured Stories
Before you consider Mesa Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.
While Mesa Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
